Semaglutide Archives

Glucagon-Like Peptide-1 Receptor Agonists and Human Fertility

by David Mcauley - January 13, 2026January 13, 2026 146

Glucagon-Like Peptide-1 Receptor Agonists and Human Fertility: Mechanisms, Evidence, and Clinical Implications Abstract Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are well established for the treatment of type 2 diabetes mellitus and obesity. Increasingly, reports suggest a possible association between GLP-1 RA use and

Emerging and Approved Therapeutic Peptides: Mechanisms, Clinical Uses

by David Mcauley - December 19, 2025December 19, 2025 0470

Emerging and Approved Therapeutic Peptides: Mechanisms, Clinical Uses, Safety Profiles, and Regulatory Status Across Health Conditions Abstract Therapeutic peptides represent a rapidly growing class of pharmaceutical agents that bridge the gap between small molecule drugs and large protein therapeutics. This paper examines the

GLP-1 Agonists for Obesity in Non-Diabetic Patients: Game Changer or Overhyped? A Critical Analysis

by Similoluwa Oluwalana - July 11, 2025July 17, 2025 0413

GLP-1 Agonists for Obesity in Non-Diabetic Patients: Game Changer or Overhyped? A Critical Analysis Please like and subscribe if you enjoyed this video :-) Abstract The treatment landscape for managing weight in non-diabetic patients has changed dramatically with the introduction of

Semaglutide Use Shows Bonus Benefit Of Osteoarthritis Risk Reduction

by Princewill Uche Okezie - July 11, 2024July 25, 2024 0458

Semaglutide Use Shows Bonus Benefit Of Osteoarthritis Risk Reduction Overview Osteoarthritis (OA) is a widespread degenerative joint condition. While the influence of obesity on OA is well-established, the effect of semaglutide on OA remains less understood. The objective was to evaluate the effect of semaglutide on the risk of OA among patients with